Pro Medicus (ASX:PME) share price down 5% on broker downgrade

This market darling’s shares have been downgraded…

| More on:
a person in a business suit wipes his forehead with his handkerchief while a red, falling arrow zigzags downwards behind him

Image source: Getty Images

The Pro Medicus Limited (ASX: PME) share price is under pressure on Monday.

At the time of writing, the healthcare technology company’s shares are down 5% to $59.00.

Despite this, Pro Medicus’ shares are still up 68% in 2021.

Why is the Pro Medicus share price tumbling?

The weakness in the Pro Medicus share price today appears to have been caused by a broker note out of Goldman Sachs.

According to the note, the broker has downgraded the company’s shares to a sell rating with a slightly reduced price target of $54.00.

Based on the current Pro Medicus share price, this represents further potential downside of 8.5% over the next 12 months.

Why did the broker downgrade its shares?

Goldman Sachs made the move on valuation grounds, believing it is hard to justify the premium the Pro Medicus share price is trading on.

Goldman explained: “Whilst we saw nothing in the FY21 result to discourage an existing positive view, we also failed to see sufficient positive surprise to justify such a strong share price reaction (+15% vs. ASX200 -1%). If valuation were no consideration, we would still be Buy-rated, reflective of a market-leading product and strong, frequent validation from a stellar customer list.”

“However, in our sector-relative framework, we do not have sufficient visibility that recent win-rates can be sustained (we believe there are fewer, large opportunities addressable in the near-term), and, if growth tapers beyond FY22E (as currently forecast), we believe the market will increasingly struggle to justify current levels (63x NTM sales; +14% CAGR FY22-25E),” it added.

In addition, the broker notes that momentum from competitors has been improving.

The broker explained: “Whilst primarily a call on valuation, we note that recent momentum from competitors has been improving, and also that, after an extended period of success, the natural runway of top-tier institutions is shortening (now in 9 of top 20 hospitals, the channel in which Visage 7 is most beneficial).”

Should you invest $1,000 in Pro Medicus right now?

Before you consider Pro Medicus, you'll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Pro Medicus wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of January 13th 2022

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Fallers

Red arrow going down and symbolising a falling share price.
Share Fallers

Why Nufarm, Pendal, Wesfarmers, and Westpac shares are sinking

These ASX shares are falling on Thursday...

Read more »

A man in a business suit plunges down a big square hole lit up in blue.
Technology Shares

The BrainChip share price just plunged 8%, what happened?

BrainChip shares were down 8% at one point today. What on earth is going on?

Read more »

Man with his head on his head with a red declining arrow and A worried man holds his head and look at his computer as the Megaport share price crashes today
BNPL shares

Zip share price dives to yet another multi-year low

The Zip share price is copping another hammering so far this Thursday...

Read more »

Concept image of US dollar in front of a graphic showing shares and a downward arrow representing the VTS ETF

Vanguard US Total Market Shares Index ETF tumbles following Wall Street sell-off

This Vanguard ETF is feeling the pain today. Here's why...

Read more »

Share Fallers

Why Boral, Eagers Automotive, PolyNovo, and Serko shares are dropping

These ASX shares are under pressure on Wednesday...

Read more »

Rede arrow on a stock market chart going down.
Share Fallers

Why Brambles, James Hardie, Seek, and Sezzle shares are sinking

These ASX shares are under pressure on Tuesday...

Read more »

man bending over to look at red arrow crashing down through the ground
Share Fallers

Australian Strategic Materials share price sinks 12% following rally

Here's what's going wrong for the critical metals producer today.

Read more »

Sad woman with her hand on her head and holding a credit card.
BNPL shares

Why is the Sezzle share price tumbling on Tuesday?

Sezzle shares are falling today after the BNPL provider released an update...

Read more »